CD19 target-engineered T-cells accumulate at tumor lesions in human B-cell lymphoma xenograft mouse models-Reference-Cited by-同舟云学术

CD19 target-engineered T-cells accumulate at tumor lesions in human B-cell lymphoma xenograft mouse models

Published:2013-08 Issue:1 Volume:438 Page:84-89
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Tsukahara Tomonori,Ohmine Ken,Yamamoto Chihiro,Uchibori Ryosuke,Ido Hiroyuki,Teruya Takeshi,Urabe Masashi,Mizukami Hiroaki,Kume Akihiro,Nakamura Masataka,Mineno Junichi,Takesako Kazutoh,Riviere Isabelle,Sadelain Michel,Brentjens Renier,Ozawa Keiya

Funder

JSPS KAKENHI

Jichi Medical University Young Investigator Award

KEIRIN RACE

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference29 articles.

1. How do CARs work?: early insights from recent clinical studies targeting CD19;Davila;Oncoimmunology,2012

2. Identification of the earliest B lineage stage in mouse bone marrow;Li;Immunity,1996

3. Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts;Brentjens;Clin. Cancer Res.,2007

4. CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells;Kowolik;Cancer Res.,2006

5. Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo;Milone;Mol. Ther.,2009

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zanubrutinib delays selinexor resistance evolution in biopsy sample-derived primary central nervous system lymphoma models;iScience;2024-05

2. Cas9-induced targeted integration of large DNA payloads in primary human T cells via homology-mediated end-joining DNA repair;Nature Biomedical Engineering;2023-12-13

3. Adjunct Therapy with T Regulatory Cells Decreases Inflammation and Preserves the Anti-Tumor Activity of CAR T Cells;Cells;2023-07-18

4. Host Interactions with Engineered T-cell Micropharmacies;Cancer Immunology Research;2023-06-28

5. Host-cell Interactions of Engineered T cell Micropharmacies;2023-04-06